Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...
An evolving understanding of the risks and benefits of HRT has led to a reevaluation of the role of HRT for breast cancer survivors.
Pooled across 34 studies data from 4.5+ million women showed that MHT use increased breast cancer odds by 15% versus non-use, but regimen-specific effects dominated the aggregate estimate.
Prognostic profiling of hormone receptor–positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors beyond progression (BP): A synthetic control arm biomarker ...
Oestrogen-induced DNA damage drives genomic instability in BRCA1 mutation cells, with dietary compounds showing protective potential.
In November 2025, the FDA initiated the removal of the “black box” warning from Hormone Replacement Therapy (HRT). HRT will ...
GIVING prostate cancer patients HRT patches could be just as effective at stopping the disease spreading, a groundbreaking ...
Health and Me on MSN
Can hormonal imbalances increase endometrial cancer risk?
Women's health is highly sensitive to hormonal changes. While an imbalance between oestrogen and progesterone can lead to ...
Think of your hormones like a backstage crew at a concert. You never notice them until they stop showing up. For millions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results